Literature DB >> 2196967

Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation.

S G Farmer1, J Togo.   

Abstract

1. We have studied the effect of epithelium removal on relaxation of guinea-pig isolated tracheal smooth muscle induced by vasoactive intestinal peptide (VIP) or stimulation of non-adrenergic, non-cholinergic (NANC) inhibitory nerves. Also examined were the effects of inhibitors of neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE). 2. Epithelium removal produced a 3.6 +/- 0.4 fold leftward shift in the VIP concentration-response curve. The supersensitivity to VIP, following epithelium removal was abolished by phosphoramidon or thiorphan (NEP inhibitors), but unaffected by captopril (an ACE inhibitor). In intact trachea, the NEP inhibitors produced leftward shifts in the VIP curves similar to those produced by epithelium removal. 3. In contrast to responses to exogenous VIP, neurogenic NANC inhibitory responses to electrical field stimulation were affected neither by epithelial denudation nor by the peptidase inhibitors. 4. As in previous studies, epithelium removal increased tracheal sensitivity to isoprenaline. This was not altered by pretreatment with a cocktail of peptidase inhibitors. Thus, the effect of the NEP inhibitors on responses to VIP appears to be relatively specific. 5. These data indicate that exogenous VIP is a substrate for airway NEP, since inhibition of the enzyme potentiates the peptide. This is further evidence that the airway epithelium provides a source for the metabolism of mediators. 6. In guinea-pig trachea the NEP responsible for cleaving VIP may be located largely in the epithelial layer, since NEP inhibition was without effect on sensitivity to VIP in epithelium-denuded preparations. If VIP is a NANC inhibitory neurotransmitter in this tissue its degradation endogenously does not appear to involve epithelial NEP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196967      PMCID: PMC1917444          DOI: 10.1111/j.1476-5381.1990.tb12054.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: lack of influence by peptidase inhibitors.

Authors:  R J Altiere; L Diamond
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

2.  Effect of alpha-chymotrypsin on the nonadrenergic noncholinergic inhibitory system in cat airways.

Authors:  R J Altiere; L Diamond
Journal:  Eur J Pharmacol       Date:  1985-08-07       Impact factor: 4.432

3.  Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.

Authors:  J R Carstairs; P J Barnes
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

4.  Pulmonary clearance of vasoactive intestinal peptide.

Authors:  M P Barrowcliffe; A Morice; J G Jones; P S Sever
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

5.  Airway epithelium modulates the reactivity of guinea-pig respiratory smooth muscle.

Authors:  D W Hay; S G Farmer; D Raeburn; V A Robinson; W W Fleming; J S Fedan
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

6.  The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

Authors:  R Matsas; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

7.  Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods.

Authors:  A Laitinen
Journal:  Eur J Respir Dis Suppl       Date:  1985

8.  The effects of epithelium removal on the sensitivity of guinea-pig isolated trachealis to bronchodilator drugs.

Authors:  S G Farmer; J S Fedan; D W Hay; D Raeburn
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

9.  Neutral metalloendopeptidase in human lung tissue and cultured cells.

Authors:  A R Johnson; J Ashton; W W Schulz; E G Erdös
Journal:  Am Rev Respir Dis       Date:  1985-09

10.  Effects of peptidases on non-adrenergic, non-cholinergic inhibitory responses of tracheal smooth muscle: a comparison with effects on VIP- and PHI-induced relaxation.

Authors:  J L Ellis; S G Farmer
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

View more
  6 in total

1.  Stimulation of sodium pump by vasoactive intestinal peptide in guinea-pig isolated trachea: potential contribution to mechanisms underlying relaxation of smooth muscle.

Authors:  K J Morrison; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors.

Authors:  S A Tannu; L M Renzetti; N Tare; J D Ventre; D Lavelle; T A Lin; A Morschauser; J Paciorek; D R Bolin; H Michel; L Singer; M Hargaden; Id Knowles; P Gardiner; M Cazzola; L Calzetta; M G Matera; A Hicks
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.

Authors:  H Aizawa; H Inoue; M Shigyo; S Takata; H Koto; K Matsumoto; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

4.  Contractile activity of big endothelin-1 on the human isolated bronchus.

Authors:  C Advenier; V Lagente; Y Zhang; E Naline
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

5.  Peptidase modulation of vasoactive intestinal peptide pulmonary relaxation in tracheal superfused guinea pig lungs.

Authors:  C M Lilly; M A Martins; J M Drazen
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  Epithelium-dependent effect of L-glutamate on airways: involvement of prostaglandins.

Authors:  Apostolia A Hatziefthimiou; Konstantinos I Gourgoulianis; Paschalis-Adam Molyvdas
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.